NYXH · Nyxoah SA · Webcasts, Transcripts & Audio
Market Cap
$147.67M
Shares
101.84M
Volume · Oct 2
68.55K
Avg daily vol (3M)
294.76K
Nyxoah SA Webcasts
Earnings calls, investor updates, investor days and conferences for Nyxoah SA (NYXH), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Earnings call
FY26 · Q3
2026-11-05
Nyxoah SA (NYXH) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-08-05
Nyxoah SA (NYXH) Q2 2026 Earnings Call Transcript
Confident tone
Reimbursement and CMS coding
International growth
Sales force expansion
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Capital Markets Day
Investor event
2026-07-08
Nyxoah SA (NYXH) July 2026 Capital Markets Day Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-12
Nyxoah SA (NYXH) Q1 2026 Earnings Call Transcript
Confident tone
Financial Performance / Margins
Market Research / Surgeon Adoption
Disciplined OpEx / Cash Runway Management
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-19
Nyxoah SA (NYXH) Q4 2025 Earnings Call Transcript
Confident tone
U.S. commercial launch momentum
Reimbursement and CMS coding
Gross margin and next-gen product roadmap
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-13
Nyxoah SA (NYXH) Q3 2025 Earnings Call Transcript
Confident tone
U.S. Commercial Launch of Genio
Reimbursement and Payer Coverage
Gross Margin Trajectory
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-18
Nyxoah SA (NYXH) Q2 2025 Earnings Call Transcript
Confident tone
Label differentiation and CCC strategy
Reimbursement and VAC/pre-authorization process
FDA PMA approval and U.S. launch
Diluted EPS
-0.55
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
Nyxoah SA (NYXH) Q1 2025 Earnings Call Transcript
Confident tone
CCC (complete concentric collapse) labeling
FDA PMA approval and manufacturing validation
Reimbursement and CPT code
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Nyxoah SA (NYXH) Q4 2024 Earnings Call Transcript
Confident tone
Genio product differentiation and DREAM clinical data
Reimbursement and CPT coding
Deferred revenue accounting change
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q2
2024-06-30
Nyxoah SA (NYXH) Q2 2024 Earnings Call Transcript
Confident tone
Genio product differentiation
European commercial performance
GLP-1 drugs and OSA market expansion
Diluted EPS
-0.43
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Nyxoah SA (NYXH) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-08
Nyxoah SA (NYXH) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Nyxoah SA (NYXH) Q2 2023 Earnings Call Transcript
Diluted EPS
-0.45
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Nyxoah SA (NYXH) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Nyxoah SA (NYXH) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Nyxoah SA (NYXH) Q3 2022 Earnings Call Transcript
Diluted EPS
-0.24
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
Nyxoah SA (NYXH) Q2 2022 Earnings Call Transcript
Diluted EPS
-0.19
Audio
Transcript
Slides
8-K10-Q
Showing 1–17 of 17 webcasts